779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
Gutierrez, Martin, Garralda, Elena, Calvo, Emiliano, Dongen, Marloes van, Eskens, Ferry, Finlay, Morgan, Menas, Fatima, Zhu, Chen, Wu, Meijing, Guillemin-Paveau, Helene, Abbadessa, Giovanni, Perez, Raymond, Yildirim, Ozlem, Naing, Aung
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squamous cell carcinoma
Meng, Robin, Even, Caroline, Licitra, Lisa, Yen, Chia-Jui, Ahn, Myung Ju, Abbadessa, Giovanni, Menas, Fatima-Zohra, Zang, Miao, Blumenschein, George
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis
Bringhen, Sara, Pour, Ludek, Vorobyev, Vladimir, Vural, Filiz, Warzocha, Krzysztof, Benboubker, Lotfi, Koh, Youngil, Maisnar, Vladimir, Karlin, Lionel, Pavic, Michel, Campana, Frank, Le Guennec, Solenn, Menas, Fatima, van de Velde, Helgi, Richardson, Paul G.
Published in Leukemia research (01.05.2021)
Published in Leukemia research (01.05.2021)
Get full text
Journal Article
Abstract 4063: SAR445877, an anti-PD-1 antibody-IL-15 mutein fusion protein restores function to exhausted T cells
Pratumchai, Isaraphorn, Bernardo, Marie, Marquardt, Kristi Lynn, Zhu, Chen, Menas, Fatima, Carrio, Roberto, Byers, Tony, Shaffer, Donald, Li, Xiangming, Teijaro, John Ross
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract CT154: Isatuximab (Isa) plus atezolizumab (Atezo) in patients (pts) with advanced malignancies: Results from a Phase 1/2 open-label multicenter study
Villar, Maria Vieito, Simonelli, Matteo, Eskens, Ferry A.L.M., Gil-Martin, Marta, Yen, Chia-Jui, Obermannova, Radka, Chao, Yee, Zagonel, Vittorina, Melichar, Bohuslav, Moreno, Victor, Yu, Ming-Lung, Bongiovanni, Alberto, Calvo, Emiliano, Rottey, Sylvie, Machiels, Jean-Pascal, González-Martín, Antonio, Paz-Ares, Luis, Chang, Chih-Long, Mason, Warren, Lin, Chia-Chi, Reardon, David, Garralda, Elena, Santoro, Armando, Meng, Robin, Abbadessa, Giovanni, Menas, Fatima, Lee, Helen, Liu, Qianying, Combeau, Cécile, Ternes, Nils, Massard, Christophe
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 2972: Preclinical characterization of SAR445877, an anti-PD-1 antibody-IL-15 mutein fusion protein with robust anti-tumor efficacy as monotherapy and in combination with PD-L1 blockade
Bernardo, Marie, Zhang, Yu-an, Lu, Dan, Martomo, Stella, Menas, Fatima, Zhu, Chen, Perez, Raymond, Patel, Jeegar, Shaffer, Donald, Li, Xiangming
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
ICARIA-MM study: efficacy analysis according to prior lines of treatment
Bringhen, Sara, Attal, Michel, Pour, Ludek, Vorobyev, Vladimir, Vural, Filiz, Warzocha, Krzysztof, Benboubker, Lofti, Koh, Youngil, Maisnar, Vladimir, KARLIN, Lionel, Pavic, Michel, Campana, Frank, Charpentier, Eric, Menas, Fatima, van de Velde, Helgi, Richardson, Paul G.
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article